Introduction of Sensitive and Specific Biomarkers Can Improve Infertility Treatment Success Rates

Approximately 20% of couples of reproductive age need assisted reproductive technologies to conceive, in spite of sophisticated improvement in the diagnosis and treatment of infertility. the cause of 30% of infertilities is unknown and less than 50% of couples are conceived by each treatment cycle using advanced assisted reproductive technologies. in the present clinical practice, many steps in the whole spectrum of diagnosis to treatment of infertility are based on the use of ambiguous biomarkers or less related ones. moreover, there are even no specific bio-markers available to determine the causes and outcomes of infertility. consequently, this condition leads to the blind performance of many diagnostic and treatment procedure with less desirable outcomes (1)